Terms: = Breast cancer AND CREBBP, CBP, 1387, ENSG00000005339, RSTS, RTS AND Prognosis
31 results:
1. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
[TBL] [Abstract] [Full Text] [Related]
2. Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
3. Exposure to endogenous and exogenous sex hormones and reproductive history influence prognosis in women with ALS.
Gonzalez Deniselle MC; Bettini M; Garrido RM; Meyer M; Lara A; Garay LI; Casas S; Fulgenzi E; Nuñez M; Rugiero MF; De Nicola AF; Gargiulo-Monachelli G
Muscle Nerve; 2023 Oct; 68(4):414-421. PubMed ID: 37493444
[TBL] [Abstract] [Full Text] [Related]
4. ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression.
Zhang Y; Wang W; Min J; Liu S; Wang Q; Wang Y; Xiao Y; Li X; Zhou Z; Liu S
Cell Rep; 2023 Jun; 42(6):112654. PubMed ID: 37342906
[TBL] [Abstract] [Full Text] [Related]
5. Mutational signatures for breast cancer diagnosis using artificial intelligence.
Odhiambo P; Okello H; Wakaanya A; Wekesa C; Okoth P
J Egypt Natl Canc Inst; 2023 May; 35(1):14. PubMed ID: 37184779
[TBL] [Abstract] [Full Text] [Related]
6. Transcriptional Repression by FoxM1 Suppresses Tumor Differentiation and Promotes Metastasis of breast cancer.
Kopanja D; Chand V; O'Brien E; Mukhopadhyay NK; Zappia MP; Islam ABMMK; Frolov MV; Merrill BJ; Raychaudhuri P
Cancer Res; 2022 Jul; 82(13):2458-2471. PubMed ID: 35583996
[TBL] [Abstract] [Full Text] [Related]
7. Machine Learning Identifies Pan-cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
8. LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related crebbp activator protein (SRCAP).
Cao W; Liu X; Su W; Liang H; Tang H; Zhang W; Huang S; Dang N; Qiao A
Bioengineered; 2022 Feb; 13(2):4573-4586. PubMed ID: 35152838
[TBL] [Abstract] [Full Text] [Related]
9. RNA-binding protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
[TBL] [Abstract] [Full Text] [Related]
10. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
[TBL] [Abstract] [Full Text] [Related]
11. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores.
Hu T; Chen Y; Liu Y; Zhang D; Pan J; Long M
BMC Med Res Methodol; 2021 May; 21(1):108. PubMed ID: 34022815
[TBL] [Abstract] [Full Text] [Related]
12. The impact of cbp expression in estrogen receptor-positive breast cancer.
Ramadan WS; Talaat IM; Hachim MY; Lischka A; Gemoll T; El-Awady R
Clin Epigenetics; 2021 Apr; 13(1):72. PubMed ID: 33827682
[TBL] [Abstract] [Full Text] [Related]
13. BOP1 confers chemoresistance of triple-negative breast cancer by promoting cbp-mediated β-catenin acetylation.
Li S; Wu H; Huang X; Jian Y; Kong L; Xu H; Ouyang Y; Chen X; Wu G; Yu L; Wang X
J Pathol; 2021 Jul; 254(3):265-278. PubMed ID: 33797754
[TBL] [Abstract] [Full Text] [Related]
14. CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer.
Craven KE; Gökmen-Polar Y; Badve SS
Sci Rep; 2021 Feb; 11(1):4691. PubMed ID: 33633150
[TBL] [Abstract] [Full Text] [Related]
15. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
[TBL] [Abstract] [Full Text] [Related]
16. A potent cbp/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer.
Li HM; Bi YR; Li Y; Fu R; Lv WC; Jiang N; Xu Y; Ren BX; Chen YD; Xie H; Wang S; Lu T; Wu ZQ
Sci Adv; 2020 Apr; 6(17):eaaw8500. PubMed ID: 32494626
[TBL] [Abstract] [Full Text] [Related]
17. lncRNA PLAC2 activated by H3K27 acetylation promotes cell proliferation and invasion via the activation of Wnt/β‑catenin pathway in oral squamous cell carcinoma.
Chen F; Qi S; Zhang X; Wu J; Yang X; Wang R
Int J Oncol; 2019 Apr; 54(4):1183-1194. PubMed ID: 30720068
[TBL] [Abstract] [Full Text] [Related]
18. LINC01857 as an oncogene regulates CREB1 activation by interacting with crebbp in breast cancer.
Xiong Y; Gu Y; Wang F; Li L; Zhu M; Wang N; Mi H; Qiu X
J Cell Physiol; 2019 Aug; 234(8):14031-14039. PubMed ID: 30628071
[TBL] [Abstract] [Full Text] [Related]
19. Activation of LncRNA TINCR by H3K27 acetylation promotes Trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast cancer.
Dong H; Hu J; Zou K; Ye M; Chen Y; Wu C; Chen X; Han M
Mol Cancer; 2019 Jan; 18(1):3. PubMed ID: 30621694
[TBL] [Abstract] [Full Text] [Related]
20. SP1-induced lncRNA AGAP2-AS1 expression promotes chemoresistance of breast cancer by epigenetic regulation of MyD88.
Dong H; Wang W; Mo S; Chen R; Zou K; Han J; Zhang F; Hu J
J Exp Clin Cancer Res; 2018 Aug; 37(1):202. PubMed ID: 30157918
[TBL] [Abstract] [Full Text] [Related]
[Next]